Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d-galactose and Aβ_1–40 injection in ovariectomized Alzheimer’s disease model rats

References

• Bean LA, Ianov L, Foster TC. 2014. Estrogen receptors, the hippocampus, and memory. Neuroscientist. 20(5):534–545.
   PubMed Web of Science ®Google Scholar
• Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA, De Jager PL. 2014. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 82(3):222–229.
   PubMed Web of Science ®Google Scholar
• Cai XJ, Huang MY, Zhang L. 2011. Research progress on the source and pharmacological effects of Erzhi pills. Chin J Exp Tradi Med Form. 17:272–275.
   Google Scholar
• Chen YH, Yan B, Guan Y, Liu YQ, Zhou YM, Huang Y, Zhou MF, Huang LP. 2019. Effect of Erjing pills on learning and memory abilities of AD rats with kidney Yin deficiency induced by ovariectomy+d-galactose combined with Aβ1-40. Tradi Chin Drug Res Clin Pharmacol. 30:1421–1427.
   Google Scholar
• Fu LL, Ding H, Han LF, Jia L, Yang WZ, Zhang CX, Hu L, Zuo TT, Gao XM, Guo DA. 2019. Simultaneously targeted and untargeted multicomponent characterization of Erzhi pill by offline two-dimensional liquid chromatography/quadrupole-Orbitrap mass spectrometry. J Chromatogr A. 1584:87–96.
   PubMed Web of Science ®Google Scholar
• Gao HL, Wang DQ, Wang XY, Wang ZG, Wang XM, Wu ZE, Liu H, Ma YY, Niu XH, Li LD. 2010. Effect of Erzhi pill (二至丸) on improving cerebral nerve cell apoptosis in aging rats. Chin J Integr Med. 16(6):504–509.
   PubMed Web of Science ®Google Scholar
• Goedert M. 2015. Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled Aβ, tau, and α-synuclein. Science. 349(6248):1255555.
   PubMed Web of Science ®Google Scholar
• Gong Y, Hua N, Zang X, Huang T, He L. 2018. Melatonin ameliorates Aβ1-42-induced Alzheimer’s cognitive deficits in mouse model. J Pharm Pharmacol. 70(1):70–80.
   PubMed Web of Science ®Google Scholar
• Hao DC, Xiao PG. 2014. Network pharmacology: a rosetta stone for traditional Chinese medicine. Drug Dev Res. 75(5):299–312.
   PubMed Web of Science ®Google Scholar
• Hou M, Fu YJ, Liu C, Wei YF, Chen YF, Xie YH, Huang LP. 2016. Effects of extraction from raspberry on hippocampus proteomics of mice suffered from ovariectomized induced AD. Chi J Chin Mater Med. 41:2895–2900.
   Google Scholar
• Hua X, Lei M, Zhang Y, Ding J, Han Q, Hu G, Xiao M. 2007. Long-term d-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer’s disease. Life Sci. 80(20):1897–1905.
   PubMed Web of Science ®Google Scholar
• Huang LP, Yan B, Hou M, Sun MS, He K, Guan Y, Yao LH, Zhou MF. 2017. Study on material basis and mechanism of Erzhi Wan prevent Alzheimer’s disease by network pharmacology. Chin J Chin Mater Med. 42:4211–4217.
   Google Scholar
• Huang LP, Yan B, Hou M, Sun MS, He K, Guan Y, Yao LH, Zhou MF. 2018. Effect of Erzhi Wan on hippocampus proteomics of mice of ovariectomized-induced AD. Chin J Exp Tradi Med Form. 24:150–156.
   Google Scholar
• Ibrahim WW, Safar MM, Khattab MM, Agha AM. 2016. 17β-Estradiol augments antidepressant efficacy of escitalopram in ovariectomized rats: neuroprotective and serotonin reuptake transporter modulatory effects. Psychoneuroendocrinology. 74:240–250.
   PubMed Web of Science ®Google Scholar
• Irvine K, Laws KR, Gale TM, Kondel TK. 2012. Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis. J Clin Exp Neuropsychol. 34(9):989–998.
   PubMed Web of Science ®Google Scholar
• Li H, Kang T, Qi B, Kong L, Jiao Y, Cao Y, Zhang J, Yang J. 2016. Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of d-galactose/AlCl3 inducing rats model of Alzheimer’s disease. J Ethnopharmacol. 179:162–169.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang L, Yang CC. 2016. Multi-target strategy and experimental studies of traditional Chinese medicine for Alzheimer’s disease therapy. Curr Top Med Chem. 16(5):537–548.
   PubMed Web of Science ®Google Scholar
• Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. 2021. PI3K/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer’s disease and Parkinson’s disease. Front Pharmacol. 12(648636):648636.
   PubMedGoogle Scholar
• Matsuo FS, Andrade MF, Loyola AM, da Silva SJ, Silva MJB, Cardoso SV, de Faria PR. 2018. Pathologic significance of AKT, mTOR, and GSK3β proteins in oral squamous cell carcinoma-affected patients. Virchows Arch. 472(6):983–997.
   PubMed Web of Science ®Google Scholar
• Pair FS, Yacoubian TA. 2021. 14-3-3 proteins: novel pharmacological targets in neurodegenerative diseases. Trends Pharmacol Sci. 42(4):226–238.
   PubMed Web of Science ®Google Scholar
• Pandey A, Mann M. 2000. Proteomics to study genes and genomes. Nature. 405(6788):837–846.
   PubMed Web of Science ®Google Scholar
• Patterson C. 2018. World Alzheimer Report 2018. The state of the art of dementia research: new frontiers. An analysis of prevalence, incidence, cost and trends. London, UK: Alzheimer’s Disease International.
   Google Scholar
• Paxinos G, Watson C. 2005. The rat brain in stereotaxic coordinates. Amsterdam: Elsevier Academic Press.
   Google Scholar
• Peri A. 2016. Neuroprotective effects of estrogens: the role of cholesterol. J Endocrinol Invest. 39(1):11–18.
   PubMed Web of Science ®Google Scholar
• Pike CJ. 2017. Sex and the development of Alzheimer’s disease. J Neurosci Res. 95(1–2):671–680.
   PubMed Web of Science ®Google Scholar
• Pirskanen M, Hiltunen M, Mannermaa A, Helisalmi S, Lehtovirta M, Hänninen T, Soininen H. 2005. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer’s disease in women. Eur J Hum Genet. 13(9):1000–1006.
   PubMed Web of Science ®Google Scholar
• Quiroz-Baez R, Ferrera P, Rosendo-Gutierrez R, Morán J, Bermúdez-Rattoni F, Arias C. 2011. Caspase-12 activation is involved in amyloid-β protein-induced synaptic toxicity. J Alzheimers Dis. 26(3):467–476.
   PubMed Web of Science ®Google Scholar
• Sadik G, Tanaka T, Kato K, Yamamori H, Nessa BN, Morihara T, Takeda M. 2009. Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J Neurochem. 108(1):33–43.
   PubMed Web of Science ®Google Scholar
• Sayas CL, Ávila J. 2021. GSK-3 and Tau: a key duet in Alzheimer’s disease. Cells. 10(4):721.
   PubMed Web of Science ®Google Scholar
• Sherwin BB. 2006. Estrogen and cognitive aging in women. Neuroscience. 138(3):1021–1026.
   PubMed Web of Science ®Google Scholar
• Sherwin BB. 2009. Estrogen therapy: is time of initiation critical for neuroprotection? Nat Rev Endocrinol. 5(11):620–627.
   PubMed Web of Science ®Google Scholar
• Shimada T, Fournier AE, Yamagata K. 2013. Neuroprotective function of 14-3-3 proteins in neurodegeneration. Biomed Res Int. 2013:564534–564511.
   PubMed Web of Science ®Google Scholar
• Song LB, Xiong HP, Li J, Liao WT, Wang L, Wu JH, Li MF. 2011. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Clin Cancer Res. 17(7):1839–1849.
   PubMed Web of Science ®Google Scholar
• Souza LC, Filho CB, Goes AT, Fabbro LD, de Gomes MG, Savegnago L, Oliveira MS, Jesse CR. 2013. Neuroprotective effect of physical exercise in a mouse model of Alzheimer’s disease induced by β-amyloid1–40 peptide. Neurotox Res. 24(2):148–163.
   PubMedGoogle Scholar
• Vorhees CV, Williams MT. 2006. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 1(2):848–858.
   PubMed Web of Science ®Google Scholar
• Walton JR. 2012. Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer’s disease, tests for susceptibility and avenues for treatment. Int J Alzheimers Dis. 2012:1–947.
   Google Scholar
• Wu JG, Wang YY, Zhang ZL, Yu B. 2015. Herbal medicine in the treatment of Alzheimer’s disease. Chin J Integr Med. 21(2):102–107.
   PubMed Web of Science ®Google Scholar
• Wu XF, Duan LX, Gao XL, Guo ML, Wang DM. 2019. Study on preventive and therapeutic effects of Erzhi pills on mice with Parkinson's disease induced by MPTP. Zhongguo Zhong Yao Za Zhi. 44:4219–4224.
   PubMedGoogle Scholar
• Zhang B, Wang Y, Li H, Xiong R, Zhao Z, Chu X, Li Q, Sun S, Chen S. 2016. Neuroprotective effects of salidroside through PI3K/Akt pathway activation in Alzheimer’s disease models. Drug Des Devel Ther. 10:1335–1343.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zheng HX, Xu Y, Lin N. 2017. Research progress in phytoestrogens of traditional Chinese medicine. Chin J Chin Mater Med. 42:3474–3487.
   Google Scholar